Bromma, Sweden

Johan Erik Simon Fredriksson

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Immunotherapy: The Path of Johan Erik Simon Fredriksson

Introduction: Johan Erik Simon Fredriksson, an eminent inventor based in Bromma, Sweden, has made significant contributions to the field of immunotherapy with his innovative patents. With a total of three patents to his name, Fredriksson focuses on developing therapeutic agents to enhance immune responses, particularly in the context of cancer treatment.

Latest Patents: Fredriksson's latest patents reflect his dedication to advancing medical science. One key patent is for a therapeutic agent that targets the receptor CLPTM1 on immune cells. This agent modulates immune system activity to treat cancer by inhibiting the growth of anti-inflammatory and immunosuppressive cells. It also stimulates antigen-presenting immune cells, aiding in the activation of anti-cancer immune responses. Another notable invention is a polypeptide designed to bind to TGF-beta, aimed at treating conditions related to elevated TGF-beta levels. This innovative polypeptide inhibits TGF-beta's interaction with CLPTM1, which may contribute to better immune system management in various diseases.

Career Highlights: Throughout his career, Johan Erik Simon Fredriksson has worked with leading companies such as Genagon Therapeutics and Olink Proteomics. His involvement with these organizations has allowed him to forge a path in biomedicine, particularly focusing on innovative solutions for complex health challenges.

Collaborations: Fredriksson has collaborated with notable professionals in the field, including Olof Andries Blokzijl and Klas Martin Lundberg. These partnerships have contributed to his success and the advanced research necessary for developing transformative therapies.

Conclusion: Johan Erik Simon Fredriksson stands out as a pioneering inventor in the landscape of immunotherapy. His patented innovations not only showcase technological advancement but also provide new hope for cancer treatment. As he continues to push the boundaries of science, the medical community eagerly anticipates the impact of his work on patient care worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…